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Abstract  
BACKGROUND: Recently, many studies regarding stroke in men and women showing differences 
in its incidence and course have been conducted, but the cause of sex differences remains unclear.  
AIM: The objective of study was to assess the incidence of selected stroke risk factors, the course 
and long-term consequences of first-ever stroke in women.  
MATERIAL AND METHODS: 304 women and 207 men with first-ever stroke were studied. We 
assessed: age at which stroke occurred; presence of hypertension, lipid disorders, coronary 
disease, atrial fibrillation, diabetes, carotid/cerebral artery stenoses; stroke aetiology, state on days 
1 (NIHSS) and 90 (Rankin).  
RESULTS: The age at which first-ever stroke occurred was higher in women (p = 0.030). Atrial 
fibrillation occurred more frequently in them (p = 0.0007). Hypertension and coronary disease 
occurred less commonly in women under 55 (p = 0.038 and 0.035 respectively). In women < 55, 
lipid disorders (p = 0.004) and diabetes (p = 0.018) were observed more rarely, they were more 
common in > 55 group (p = 0.042 and 0.023). In women, carotid artery stenoses were less common 
(p = 0.07), cardiogenic stroke more common (p = 0.001). They were in worse neurological state 
both on day 1 (p = 0.001) and 90 (p = 0.033) of disease.  
CONCLUSIONS: Cardiogenic stroke is significantly more common in women. Women exhibit more 
severe post-stroke disability, resulting in more frequent use of institutional care.  
 
 
 
 
 
Introduction 
The profile of risk factors for stroke shows a 
relationship with gender. In recent years, there have 
been a number of studies regarding stroke in men and 
women, in which differences in the incidence and the 
course of ischemic stroke were shown, but the cause 
of gender differences often remains unclear. Women 
more rarely suffer from stroke, but only before 
menopause – differences among the elderly become 
blurred [1]. They experience ischemic stroke more 
frequently as a result of cardiogenic embolism, which 
is associated with a higher mortality rate and severe 
disability [2]. Post-stroke depression and dementia are 
more common among women [3, 4]. Differences in 
response to thrombolytic treatment in the acute phase 
of stroke and endovascular treatment in secondary 
prevention are also observed [5-7]. The protective 
impact of oestrogens on cerebral circulation, 
modifying the process of atherogenesis, is 
emphasised [8]. Study results obtained by 
researchers are often contradictory; this is associated, 
among other things, with the influence of 
geographical, race-related and individual factors. In 
literature, there are few reports raising the issue of the 
importance of sex in stroke [9]. An analysis of the 
distribution of risk factors for stroke in women, as well 
as differences in the course of the acute phase of the 
disease and its outcome may be helpful in optimising 
preventive and therapeutic strategies regarding 
stroke. 
The objective of this study was to assess the 
course and long-term consequences of first-ever 
ischemic stroke in women and to determine the 
incidence of selected risk factors for stroke in this 
group.  
 
Material and Methods 
In 2012-2013, 511 patients participated in the 
prospective study: 304 women (the study group) aged 
32-100 years (median 74 years, Q25% = 66 years, 
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Q75% = 81 years) and 207 men (the reference group) 
aged 42-99 years (median 70 years, Q25% = 61 
years, Q75% = 77 years). The inclusion criterion for 
the study was a first-ever symptomatic ischemic 
stroke or reversible ischemic neurological deficit) 
diagnosed in accordance with World Health 
Organisation (WHO) criteria (1980) [10].  
Patients with symptoms of a transient 
ischemic attack or acute intracranial bleeding 
complicated by ischemic stroke due to angiospasm 
were not included. Patients meeting the inclusion 
criteria and consecutively admitted to the Neurology 
Department for treatment of the acute phase of 
ischemic stroke participated in the study. The study 
included patients in whom head computed 
tomography (CT) scans performed in the first 24 hours 
of stroke revealed no lesions or new ischemic lesions. 
Clinically silent “old” vascular foci were found in 86 
patients. 
The following were recorded in all of the 
included patients: 
 the age at which their first-ever ischemic 
stroke occurred 
 the presence of the following diseases:  
arterial hypertension (HA), coronary artery disease 
(CAD), atrial fibrillation (AF), diabetes mellitus (DM) 
and lipid disorders (based on laboratory tests carried 
out beforehand and during hospitalisation as well as 
the conclusions of general medicine consultations).  
The diagnoses of arterial hypertension were 
established on the basis of the diagnostic criteria of 
the Polish Cardiac Society [11]. The diagnosis of 
ischaemic heart disease was posted earlier, or the 
data from the patient's medical history or family history 
reflected the presence of typical symptoms of the 
disease, or it was stated on the basis of the 
electrocardiography (ECG) image (past myocardial 
infarction, characteristics of myocardial ischemia), or 
ultrasound cardiography (segmental left ventricular 
dysfunction of contractility, reduced ejection fraction, 
EF). The diagnosis related to atrial fibrillation was 
posted when arrhythmia was recognized in the 
previous patient records or if it was present in the 
ECG during current hospitalization. The presence of 
the enumerated diseases, and conditions considered 
as risk factors for cerebral stroke was based on the 
tests, and specialist consultations performed during 
hospitalization and/or after the analysis of existing 
patients’ medical records. During hospitalization, 
continuous ECG monitoring was carried out for 3 days 
during the acute period of the disease. ECG-holter 
test was carried out once; transthoracic 
echocardiography, and 3-fold measurement of arterial 
blood pressure was taken during each day of 
hospitalization.  
The concentrations of total cholesterol >200 
mg/dl (>5.18 mmol/L), LDL >100 mg/dl (2.59 mmol/L), 
HDL <35mg/dl (0.91 mmol/L) and triglycerides >135 
mg/dl (1.53mmol/L) were assumed to be abnormal.  
 the presence of haemodynamically significant 
stenoses of the carotid and/or cerebral arteries found 
on ultrasound examinations performed on the 1st and 
8th days of the disease using an EnVisor system, 
manufactured by Philips, and a PIONEER device, 
manufactured by EME. Stenoses considered being 
significant haemodynamically:  ≥ 70% of the carotid 
artery and/or ≥ 50% of the cerebral artery ipsilaterally 
to the cerebral ischemia (the NASCET criteria were 
used). 
 the neurological state in the first 24 hours of 
stroke according to the NIHSS (National Institutes of 
Health Stroke Scale) [12] 
 the neurological state at day 90 following the 
onset of the disease according to the Rankin scale 
[13]  
 the anatomical location of the cerebral 
vascular event, specified as: vessels supplying the 
internal carotid artery or the basilar artery  
A-S-C-O scale was used to assess the main 
causes of stroke. In this phenotype-based 
classification, every patient was characterized by A-S-
C-O: A for atherosclerosis, S for small vessel disease, 
C for cardiac source, O for other cause. Each of the 4 
phenotypes was graded 1, 2, or 3. One for 'definitely a 
potential cause of the index stroke', 2 for 'causality 
uncertain', 3 for 'unlikely a direct cause of the index 
stroke (but disease is present)'. When the disease 
was completely absent, the grade was 0; when 
grading was not possible due to insufficient work-up, 
the grade was 9. 
Multiple logistic regression was performed in 
order to assess the impact of sex and age (under and 
over 55 years) on the occurrence of HA, CAD, DM, 
lipid disorders; log-linear models were used in order to 
assess the impact of sex on the cause of stroke 
according to the ASCO scale.  
The statistical suite Statistica v. 7.1 PL by 
StatSoft and MedCalc v. 12.04 by MedCalc Software 
were used in multiple factor assessment. 
The analyses were carried out with respect to 
the whole group of men and women, and then after 
dividing each of them into two age subgroups: under 
and over 55 years. It is consistent with the categories 
used in a number of studies, which the authors of the 
presented report refer to. The following tests were 
used during the statistical analysis: the D'Agostino-
Pearson test – to verify the consistency of the 
distribution of the examined characteristic (age) with 
the normal distribution; the Mann-Whitney test – for 
intergroup comparisons, the Chi-square test – to verify 
the independence of two qualitative characteristics. A 
value of p < 0.05 was accepted as statistically 
significant. 
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Results  
The age at which first-ever ischemic stroke 
occurred was significantly higher in women (median 
74 years, SD = 11.57 years, Q25% = 66 years, Q75% 
= 81 years) compared to men (median 70 years, SD = 
10.92 years, Q25% = 61 years, Q75% = 77 years) 
(Table 1).  
Table 1: Comparison of prevalence of selected risk factors and 
concerning course of stroke in women and men. 
Parameters 
Female (F) 
n (%) 
Male (M) 
n (%) 
F vs M 
p 
Median age at of first-ever stroke  
74 
Q25% = 66  
Q75% = 81 
70  
Q25% = 61 
 Q75% = 77 
<0.001 
NIHSS on 1
st
 day 
 
7.12 5.63 0.001 
Atrial fibrillation 101 (33.22) 41 (19.81) <0.001 
Arterial hypertension 273 (89.80) 182 (87.92) 0.506 
Coronary Heart Disease 152 (50.00) 91 (44.17) 0.195 
Diabetes 137 (45.07) 77 (37.20) 0.076 
Lipid disturbances 156 (46.38) 96 (51.32) 0.272 
A 35 (11.5%) 42 (20.3%) 0.006 
S 97 (31.9) 64 (30.9%) 0.813 
C 106 (34.9%) 45 (21.7%) 0.001 
O 66 (21.7%) 56 (27.1%) 0.164 
Anatomical 
location of stroke 
ICA 235 (77.30) 151 (72.95)  
0.26 BA 69 (22.70) 56 (27.05) 
mRankin > 3 points 
on 90
th
 day, n 
72 35 0.033 
Using the services of residential 
care facilities, n 
53 20 0.02 
Mortality, n 68 45 0.74 
 
NIHSS- National Institutes of Health Stroke Scale; ICA- internal catrotid artery; BA- basilar 
artery; A- S- C- O- (phenotypic) classification of stroke: A for  atherosclerosis,  S for small-
vessel disease,  C for cardiac pathology, O for other causes. 
 
Atrial fibrillation occurred significantly more 
frequently in women than in men (p < 0.001), which 
resulted from significantly more common atrial 
fibrillation in women over 55 years (p = 0.0007) 
(Tables 1, 2). The percentage of haemodynamically 
significant carotid artery stenoses was lower in 
women (11.51% vs. 20.37% in men, p = 0.07). The 
neurological state in the first 24 hours of the disease, 
according to the NIHSS, was found to be more severe 
in women than in men (the mean score in women: 
7.12; the mean score in men: 5.63; p = 0.001) (Table 
1). Women obtained statistically significantly higher 
scores on the Rankin scale at day 90 following the 
onset of stroke (>3 points in 72 women and in 35 men; 
p=0.033) and more often used the services of 
residential care facilities in comparison with men 
(17.36% vs. 9.71%) (Table 1). Women significantly 
often suffered from cardiogenic stroke (34.9% vs 
21.7%; p = 0.001) (Table 1). The impact of the classic 
risk factors for stroke, atrial fibrillation, arterial 
hypertension, lipid disorders and diabetes, depended 
on age to a large extent in both groups. Arterial 
hypertension and ischemic heart disease occurred 
significantly more rarely in women aged under 55 age 
group (p = 0.038 and p = 0.035, respectively) (Table 
2). Similarly, lipid disorders (p = 0.004) and diabetes 
(p = 0.018) were significantly less observed in women 
in the same age group; however, among older 
patients, both diseases were significantly more 
common in women (p = 0.042 and p = 0.023, 
respectively) (Table 2).  
 
Table 2: Comparison of the prevalence of selected risk factors 
for stroke and parameters of stroke in men and women ≤ and > 
55 years of age. 
 
Female 
≤ 55 
years 
Male 
≤ 55 
years 
p 
Female 
>55 
years 
Male 
>55 
years 
p 
n 22 27  282 180  
Atrial fibrillation 2 4 0.538 99 37 0.000 
Arterial 
hypertension 
13 23 0.038 260 159 0.167 
Coronary Heart 
Disease 
2 9 0.035 82 150 0.122 
Diabetes 2 10 0.018 135 67 0.023 
Lipid disturbances 5 17 0.004 151 79 0.042 
Anatomical 
location of 
stroke 
ICA 22 17 
 
0.002 
213 134 
 
0.79 BA 0 10 69 46 
ICA- internal catrotid artery; BA- basilar artery. 
 
In women aged  under 55 years, in 
comparison with men, stroke located within the blood 
vessels supplying the basilar artery was significantly 
more rare (p = 0.002) (Table 2). Age had a statistically 
significant effect on the incidence of HA (OR = 3.46,CI 
1.69-7.07, p = 0.0006), CAD (OR = 3.40,CI 1.69-6.84, 
p = 0.0006), AF (OR = 2.73,CI 1.13-6.62, p = 0.025), 
DM (OR = 2.29,CI 1.16-4.53, p = 0.016). Neither sex 
nor age mattered in relations to the occurrence of lipid 
disorders (significance level for model p = 0.47). 
Female gender was important for the cardiogenic 
mechanism of cerebral stroke (p = 0.0018). There was 
no statistically significant effect of age on the patho-
mechanism of cerebral ischemia (p = 0.1992). 
 
Discussion 
Atrial fibrillation occurs more commonly in 
older individuals and in women. Among individuals 
aged 60 years and younger, the incidence of AF is 
estimated at 0.1-0.2%, while in individuals over the 
age of 80 years, it is 9.1–11% [14-16]. The older age 
of women at the onset of first-ever ischemic stroke 
may explain why this arrhythmia causes cerebral 
ischaemia more often in women than in men. In the 
presented study, like other authors, we found a 
significantly higher incidence of AF in women. 
Humphries observed a higher heart rate during AF in 
the acute phase of stroke in women [17]. The increase 
in heart rate and parasympathetic nervous system 
dysfunction may result from the older age of women 
with AF and arrhythmogenic thyroid diseases, which 
are more common among them [18]. The female 
gender has been recognised as a negative parameter 
in the CHA2DS2VaSc score, which stratifies the 
annual stroke risk in patients with AF [19].  
In our study, we found haemodynamically 
significant carotid and cerebral artery stenoses less 
often in women. It is consistent with the results of the 
available research which indicates a higher incidence 
of symptomatic peripheral artery disease in men [20-
22]. The impact of the risk factors for atherosclerosis, 
including modifiable ones, which are associated with 
lifestyle and more often observed in men, is 
noticeable. The analysis of the incidence of other, 
apart from AF and carotid artery disease, risk factors 
for stroke did not reveal significant differences 
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between men and women. They were, however, 
observed after dividing the study groups into age 
subgroups. We found a significantly lower incidence of 
arterial hypertension in women in comparison with 
men in the fewer than 55 age group; no significant 
difference was found in older patients. Arterial 
hypertension is the cause of alterations in the 
structure of the walls of cerebral arteries and 
arterioles, this leads to haemodynamic changes 
associated with a shift in the limits of autoregulation 
towards higher blood pressure. The available 
literature on the epidemiology of arterial hypertension 
describes its higher incidence in women or men, or 
the lack of gender-related differences [20, 23-26].  
Literature data suggest a lower incidence of 
lipid disorders in women, which is also consistent with 
our observations regarding patients aged up to 55 
years. We found a reversal of this relationship in older 
individuals. According to Zang et al., abnormal LDL 
levels are a risk factor for stroke in both genders, 
while elevated total cholesterol is associated with the 
risk of stroke only in women [27]. The use of statins 
decreases the risk of stroke and other cardiovascular 
events both in men and in women [28]. As previous 
studies have shown, women more rarely use lipid-
lowering therapy [29, 30]. The analyses were carried 
out not taking age categories into account. 
We observed age-dependent differences in 
the incidence of diabetes – significantly less common 
in women aged less than 55 years and significantly 
more common among older female patients in 
comparison with men in the same age group. The 
consequences of diabetes are negatively affected by 
the profile of disorders accompanying it which are 
categorised as elements of the metabolic syndrome. 
In a study of the Danish population, it was found that 
type 2 diabetes doubles the risk of stroke in men, but 
its negative impact is significantly stronger in women 
[31]. Women use hypoglycaemic agents less often 
[30].  
Analysing risk factors for stroke, we found a 
lower incidence of arterial hypertension, ischemic 
heart disease, and diabetes and lipid disorders in 
women aged up to 55 years. It may have an influence 
on the older age at which first-ever stroke occurs in 
them. In our study, the mean difference was 4.1 
years. Similar observations regarding the difference in 
age at which the disease occurred have been 
presented by other authors [4, 20, 24, 29, 31].  In 
women aged under 55 years, in comparison with men, 
ischemia occurring in the blood vessels supplying the 
basilar artery was significantly more rare (p = 0.002). 
According to single reports, women more frequently 
suffer from cerebral infarction in the area supplied by 
the arteries of the anterior Circle of Willis [32]. 
According to other authors, the location of the area of 
cerebral ischemia is not related to gender [33-35].  
In our study, we observed more severe 
neurological conditions in women both in the acute 
phase of stroke and three months later. Similar results 
were presented by other authors [20, 33, 36]. The 
presence of risk factors, including atrial fibrillation, has 
an undoubted impact on the neurological condition 
during stroke. Literature data indicate that cardiogenic 
stroke has a more severe course, which usually 
results from the large size of embolic material 
generated in the heart. Lower limb osteoarthritis, 
obesity, lower extremity venous insufficiency and 
osteoporosis can limit the effects of rehabilitation and 
improvement in ability in women. Our female patients 
used the services of residential care facilities due to 
post-stroke disability far more frequently than men. 
The impact of gender on the incidence, 
course and outcome of stroke is analysed while taking 
the hormone profile into consideration. A hypothesis 
concerning the role of oestrogen as a neuro- and 
vasoprotective factor was proposed on the basis of 
the results of experimental cerebral ischemia in 
rodents [8]. In female animals, occlusion of the middle 
cerebral artery leads to the appearance of smaller 
infarction foci. After ovariectomy, the size of the foci is 
comparable between members of both sexes; 
however, oestrogen substitution leads to a reduction 
in the size of the area affected by ischemia [37, 38]. 
 The regulatory impact of estradiol on blood 
flow, its dilating, antithrombotic and anti-inflammatory 
effects are emphasised [8, 39]. Oestrogens reduce 
the tone of the smooth muscles of blood vessel walls, 
increase the production of endothelial nitric oxide, and 
have a stabilising effect on the blood-brain barrier [8]. 
The neuroprotective activity of endogenous 
oestrogens expires after menopause, and the 
importance of hormone replacement therapy for the 
incidence of stroke is unknown [40]. Although that 
many studies show a beneficial effect of endogenous 
estrogen on the vasculature; there are a few studies 
with the contrary results. Pappa at al. identified an 
independent association of endogenous estradiol 
levels with stroke severity and short-term mortality 
and outcome [41]. In recent years, attention is drawn 
to estrogen in the context of its proinflammatory role 
and its interaction with aging [42]. 
Limitations: This study has some limitations: 
the lack of analysis of smoking, alcohol consumption 
and oral contraceptive as risk factors for stroke. 
The results of the presented study allow us to 
draw the following conclusions:   
- Cardiogenic stroke is more common in 
women.  
- Women exhibit a higher level of post-stroke 
disability, which results in more frequent use 
of residential care. 
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